The likelihood of finding a cure for the chronic neurodegenerative disease known as Alzheimer’s is increasing, thanks to a joint research project by Syntronic Gothenburg, the University of Gothenburg (GU), and the Karolinska Institute (KI). The team is about to release a brain network analysis software that will be used by medical professionals all over the world – and bring hope to the 35 million Alzheimer’s patients.
Today, over 50 million people suffer from severe memory loss that at best erases the image of what they did five minutes ago – and at worst makes their own children look like strangers. Roughly 70 % of them are diagnosed with Alzheimer’s. Every year, an additional ten million families receive the news that a parent or spouse is affected.
Mercifully, scientists are on the verge of alleviating the suffering. At the forefront of the battle, Syntronic, KI and GU push the frontiers forward through enabling new ways of gathering information about the workings of the human brain.
Syntronic’s team consists of highly skilled researchers and engineers with extensive expertise within various focus areas. Their current mission, in partnership with the University of Gothenburg and Karolinska Institute, is to perfectionate a software that will make it possible to analyse the human brain network in greater detail. A crucial goal when it comes to Alzheimer’s and other neurological disease is to comprehend how they emerge and progress in the brain. That knowledge will hopefully enable the development of treatments and a cure.
Today, scientists have no answers to why Alzheimer’s and other neurodegenerative diseases develop and cannot be eradicated. What they do know is that the human brain is structured as a complex network with various regions that interact with each other. That interaction can now be studied, courtesy of the software Syntronic, GU, and KI are developing, known as brain analysis using graph theory (BRAPH). According to the researchers responsible for the project, it will unveil new information about the brain’s structure, how brain signals evolve and how pathological molecules disperse throughout the brain way.
Essential knowledge on the brain’s organisation and structure will be derived by the software, from magnetic resonance imaging (MRI), functional MRI (fMRI), positron emission tomography (PET) and electroencephalogram (EEG) data. Once that information is acquired, scientists can analyse how the brain networks of patients with neurological conditions differ from those of healthy individuals.
In addition, the software will enable comparisons of the same patient’s brain at different points in time. Combined, the new information that medical professionals will access courtesy of the software will increase the likelihood that a cure will see the light of day significantly.
Syntronic is a leading design house specializing in advanced product and systems development, production and aftermarket services. Among our customers and partners are some of the world’s most technology intensive businesses and organizations in sectors such as telecom, automotive, defence, industrial and medtech.